Sino-Singapore medical center in Huangpu spearheads cancer treatment innovations

On Feb 28, the China-Singapore Guangzhou Knowledge City (CSGKC) celebrated the inauguration of the Sino-Singapore Cancer Treatment Technology Innovation and Clinical Transformation Medical Center, signifying a leap in collaborative medical innovation efforts between China and Singapore.

Dedicated to the research, development, and clinical application of cancer treatment technologies, the center is at the forefront of advancing the industrialization of cutting-edge sciences such as gene and cell therapy.

The establishment of the medical center not only strengthens technological collaboration in Sino-Singapore but also delivers tangible benefits to both sides. Its launch solidifies CSGKC's role as a preferred entry point for Singaporean enterprises entering the Guangdong-Hong Kong-Macao Greater Bay Area.

Furthermore, the creation of the medical center is expected to accelerate the transformation of scientific research findings, offering new treatment options for cancer patients. It stands as a positive impact of Sino-Singapore cooperation in promoting the high-quality development of the biopharmaceutical industry.

Share - WeChat